Volpara Health Technologies Umsatz
Was ist das Umsatz von Volpara Health Technologies?
Umsatz von Volpara Health Technologies Limited ist NZD$37.960M
Was ist die Definition von Umsatz?
Umsatz sind die Einnahmen, die ein Unternehmen aus seiner normalen Geschäftstätigkeit erzielt, normalerweise aus dem Verkauf von Waren und Dienstleistungen an Kunden.
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Umsatz von Unternehmen in Health Care Sektor auf ASX im Vergleich zu Volpara Health Technologies
Was macht Volpara Health Technologies?
Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device and practice management software industry worldwide. The company offers Volpara Analytics software, a cloud-based breast imaging analytics platform that delivers performance monitoring solutions; Volpara Live, which provides radiographers instant patient-based image quality feedback; Volpara Lung, a patient management software; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses Tyrer-Cuzick v8 Risk Evaluation Tool to calculate patients' risk of developing breast cancer; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. Volpara Health Technologies Limited has a strategic relationship with RevealDx to enhance lung screening capabilities. The company was formerly known as Matakina Technology Ltd. and changed its name to Volpara Health Technologies Limited in October 2015. Volpara Health Technologies Limited was incorporated in 2009 and is headquartered in Wellington, New Zealand.
Unternehmen mit umsatz ähnlich Volpara Health Technologies
- Cumberland Pharmaceuticals hat Umsatz von $37.786M
- Longtable hat Umsatz von AUD$37.805M
- Jatenergy hat Umsatz von AUD$37.856M
- D-BOX Technologies hat Umsatz von CAD$37.870M
- Flexible Solutions International Inc hat Umsatz von $37.900M
- IQGeo plc hat Umsatz von £37.940M
- Volpara Health Technologies hat Umsatz von NZD$37.960M
- Kalray S.A hat Umsatz von €38.000M
- Boss Resources hat Umsatz von AUD$38.037M
- Protalix BioTherapeutics hat Umsatz von $38.053M
- Enterprise hat Umsatz von CAD$38.070M
- Tai Kam hat Umsatz von HKD$38.130M
- Mirati Therapeutics Inc hat Umsatz von $38.191M